So essentially your BUY case for IPD is reliant upon the litigation culture of the US, rather than any benefits for patients?
Ann: New Clinical Practice Guidance Recommends Use of BIS, page-30
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
0.004(5.00%) |
Mkt cap ! $169.9M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.4¢ | 8.0¢ | $256.5K | 3.159M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 121194 | 2 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.3¢ |
Change
0.004 ( 3.75 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.4¢ | 7.9¢ | 1002631 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| IPD (ASX) Chart |